Pheochromocytoma presenting with severe hyperglycemia and metabolic acidosis following intra-articular glucocorticoid administration: a case report.
Acidosis
/ chemically induced
Adrenal Gland Neoplasms
/ complications
Adrenal Glands
/ diagnostic imaging
Glucocorticoids
/ administration & dosage
Humans
Hyperglycemia
/ chemically induced
Injections, Intra-Arterial
Japan
Male
Middle Aged
Pheochromocytoma
/ chemically induced
Tomography, X-Ray Computed
Diabetic ketoacidosis
Fulminant type 1 diabetes
Glucocorticoid
Hyperglycemia
Pheochromocytoma
Journal
Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382
Informations de publication
Date de publication:
05 Jan 2019
05 Jan 2019
Historique:
received:
24
07
2018
accepted:
06
12
2018
entrez:
6
1
2019
pubmed:
6
1
2019
medline:
2
5
2019
Statut:
epublish
Résumé
There are several reports of pheochromocytoma crisis triggered by systemic glucocorticoid administration. However, pheochromocytoma crisis after intra-articular glucocorticoid administration has been rarely reported. A 45-year-old Japanese man presented to our hospital with a sudden, severe headache. He had no history of diabetes. He had received an intra-articular injection of betamethasone (2 mg) for joint pain, 2 days prior to his admission. On examination, his blood pressure was 240/126 mmHg and pulse was 120 beats/minute. The possibility of cerebrovascular events was ruled out by imaging studies and lumbar puncture. Blood tests revealed severe hyperglycemia (523 mg/dL) and metabolic acidosis (pH 7.21, anion gap 26.2 mEq/L, lactate 11.75 mmol/L) with a glycosylated hemoglobin level of 5.7%. Although a urine sample could not be obtained, fulminant type 1 diabetes mellitus and diabetic ketoacidosis were suspected based on these findings. However, after the initial treatment for diabetic ketoacidosis, his insulin secretion was found to be normal and the plasma levels of ketones were not elevated. This excluded the possibility of fulminant type 1 diabetes mellitus and diabetic ketoacidosis. Subsequently, a left adrenal gland tumor and elevated levels of serum catecholamine and urinary catecholamine metabolites were detected, while his other hormone levels were normal. Serum catecholamine levels did not decrease following the clonidine test, and a functional scintigraphy using iodine-131 metaiodobenzylguanidine showed strong uptake in the region of the left adrenal gland. Although no signs of pheochromocytoma crisis, such as paroxysmal hyperglycemia and hypertension, had been observed since admission, a pheochromocytoma was diagnosed based on the investigations. After controlling his blood pressure, a left adrenalectomy was performed. This case illustrates that intra-articular glucocorticoid administration can induce a pheochromocytoma crisis and an increase in hyperglycemia, and that pheochromocytoma crisis can resemble the clinical picture of fulminant type 1 diabetes mellitus owing to severe hyperglycemia with metabolic acidosis and normal glycosylated hemoglobin levels, especially under the influence of glucocorticoid.
Sections du résumé
BACKGROUND
BACKGROUND
There are several reports of pheochromocytoma crisis triggered by systemic glucocorticoid administration. However, pheochromocytoma crisis after intra-articular glucocorticoid administration has been rarely reported.
CASE PRESENTATION
METHODS
A 45-year-old Japanese man presented to our hospital with a sudden, severe headache. He had no history of diabetes. He had received an intra-articular injection of betamethasone (2 mg) for joint pain, 2 days prior to his admission. On examination, his blood pressure was 240/126 mmHg and pulse was 120 beats/minute. The possibility of cerebrovascular events was ruled out by imaging studies and lumbar puncture. Blood tests revealed severe hyperglycemia (523 mg/dL) and metabolic acidosis (pH 7.21, anion gap 26.2 mEq/L, lactate 11.75 mmol/L) with a glycosylated hemoglobin level of 5.7%. Although a urine sample could not be obtained, fulminant type 1 diabetes mellitus and diabetic ketoacidosis were suspected based on these findings. However, after the initial treatment for diabetic ketoacidosis, his insulin secretion was found to be normal and the plasma levels of ketones were not elevated. This excluded the possibility of fulminant type 1 diabetes mellitus and diabetic ketoacidosis. Subsequently, a left adrenal gland tumor and elevated levels of serum catecholamine and urinary catecholamine metabolites were detected, while his other hormone levels were normal. Serum catecholamine levels did not decrease following the clonidine test, and a functional scintigraphy using iodine-131 metaiodobenzylguanidine showed strong uptake in the region of the left adrenal gland. Although no signs of pheochromocytoma crisis, such as paroxysmal hyperglycemia and hypertension, had been observed since admission, a pheochromocytoma was diagnosed based on the investigations. After controlling his blood pressure, a left adrenalectomy was performed.
CONCLUSIONS
CONCLUSIONS
This case illustrates that intra-articular glucocorticoid administration can induce a pheochromocytoma crisis and an increase in hyperglycemia, and that pheochromocytoma crisis can resemble the clinical picture of fulminant type 1 diabetes mellitus owing to severe hyperglycemia with metabolic acidosis and normal glycosylated hemoglobin levels, especially under the influence of glucocorticoid.
Identifiants
pubmed: 30609924
doi: 10.1186/s13256-018-1945-z
pii: 10.1186/s13256-018-1945-z
pmc: PMC6320610
doi:
Substances chimiques
Glucocorticoids
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3Références
Mod Pathol. 1999 Dec;12(12):1107-11
pubmed: 10619262
Jpn Circ J. 2000 Oct;64(10):785-8
pubmed: 11059621
Am J Surg Pathol. 2002 May;26(5):551-66
pubmed: 11979086
Diabetes Care. 2003 Aug;26(8):2345-52
pubmed: 12882860
J Hypertens. 2003 Sep;21(9):1703-7
pubmed: 12923403
Cleve Clin J Med. 1992 Jul-Aug;59(4):423-7
pubmed: 1525976
Eur J Endocrinol. 2008 Mar;158(3):423-9
pubmed: 18299478
Pol J Pathol. 2013 Jun;64(2):129-35
pubmed: 23900871
Ann Intern Med. 1986 Dec;105(6):880-2
pubmed: 3777712
J Clin Endocrinol Metab. 1980 Oct;51(4):930-3
pubmed: 6999003
Ann Rheum Dis. 1981 Dec;40(6):571-4
pubmed: 7332377
Diabetes Res Clin Pract. 1996 Sep;34(1):57-60
pubmed: 8968691